We demonstrated that, in distinction to classical opioid receptors, ACKR3 doesn't trigger classical G protein signaling and isn't modulated by the classical prescription or analgesic opioids, such as morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. In its place, we recognized that LIH383, an ACKR3-selective https://michelangelos426xgu3.losblogos.com/profile